A new HPLC method to determine DONEPEZIL HYDROCHLORIDE (cas 110119-84-1) in tablets

Add time:08/15/2019    Source:sciencedirect.com

A HPLC stability-indicating assay for DONEPEZIL HYDROCHLORIDE (cas 110119-84-1) in tablets was developed and validated. Donepezil hydrochloride is a reversible inhibitor of acetylcholinesterase, indicated for the treatment of mild to moderate dementia of the Alzheimer's type. The HPLC method was performed with a reversed phase C18 column, detection at 268 nm and a mixture of methanol, phosphate buffer 0.02 M and triethylamine (50:50:0.5) as mobile phase. Typical retention time for Donepezil was 9 min. The method was statistically validated for linearity, accuracy, precision and selectivity following ICH recommendations. Due to its simplicity and accuracy, the method can be used for routine quality control analysis.

We also recommend Trading Suppliers and Manufacturers of DONEPEZIL HYDROCHLORIDE (cas 110119-84-1). Pls Click Website Link as below: cas 110119-84-1 suppliers

Prev:Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil
Next:New gradient high-performance liquid chromatography method for determination of DONEPEZIL HYDROCHLORIDE (cas 110119-84-1) assay and impurities content in oral pharmaceutical formulation)